Cite
Long-Term Results of Immunogenicity of Booster Vaccination against SARS-CoV-2 (Hybrid COV-RAPEL TR Study) in Turkiye: A Double-Blind, Randomized, Controlled, Multicenter Phase 2 Clinical Study.
MLA
Ates, Ihsan, et al. “Long-Term Results of Immunogenicity of Booster Vaccination against SARS-CoV-2 (Hybrid COV-RAPEL TR Study) in Turkiye: A Double-Blind, Randomized, Controlled, Multicenter Phase 2 Clinical Study.” Vaccines, vol. 11, no. 7, July 2023, p. 1234. EBSCOhost, https://doi.org/10.3390/vaccines11071234.
APA
Ates, I., Batirel, A., Aydin, M., Karadag, F. Y., Erden, A., Kucuksahin, O., Armagan, B., Guven, S. C., Karakas, O., Gokdemir, S., Altunal, L. N., Buber, A. A., Gemcioglu, E., Zengin, O., Inan, O., Sahiner, E. S., Korukluoglu, G., Sezer, Z., Ozdarendeli, A., & Omma, A. (2023). Long-Term Results of Immunogenicity of Booster Vaccination against SARS-CoV-2 (Hybrid COV-RAPEL TR Study) in Turkiye: A Double-Blind, Randomized, Controlled, Multicenter Phase 2 Clinical Study. Vaccines, 11(7), 1234. https://doi.org/10.3390/vaccines11071234
Chicago
Ates, Ihsan, Ayse Batirel, Mehtap Aydin, Fatma Yilmaz Karadag, Abdulsamet Erden, Orhan Kucuksahin, Berkan Armagan, et al. 2023. “Long-Term Results of Immunogenicity of Booster Vaccination against SARS-CoV-2 (Hybrid COV-RAPEL TR Study) in Turkiye: A Double-Blind, Randomized, Controlled, Multicenter Phase 2 Clinical Study.” Vaccines 11 (7): 1234. doi:10.3390/vaccines11071234.